0.80

29.09% 0.1803

After Hours: .72 -0.08 -10.00%

Celularity Inc (CELU)

Overview News Price History Option Chain Financials Discussions Forecast

Celularity Inc stock is traded at $0.80, with a volume of 947.09K. It is up +29.09% in the last 24 hours and down -8.29% over the past month. Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Previous Close:

$0.6197

Open:

$0.63

24h Volume:

947.09K

Relative Volume:

8.09

Market Cap:

$23.16M

Revenue:

$26.55M

Net Income/Loss:

$-91.72M

P/E Ratio:

-0.2232

EPS:

-3.584

Net Cash Flow:

$-13.25M

1W Performance:

+31.95%

1M Performance:

-8.29%

6M Performance:

-36.00%

1Y Performance:

-59.60%

1-Day Range:

$0.63

$0.86

1-Week Range:

$0.5601

$0.86

52-Week Range:

$0.5601

$4.35

Celularity Inc Stock (CELU) Company Profile

Name

Celularity Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

(908) 768-2170

Address

170 PARK AVE, FLORHAM PARK

Employee

115

Twitter

Next Earnings Date

2026-05-08

Latest SEC Filings

CELU's Discussions on Twitter

Compare CELU vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CELU Celularity Inc	0.80	17.31M	26.55M	-91.72M	-13.25M	-3.584
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Celularity Inc Stock (CELU) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-30-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Dec-22-22	Downgrade	Oppenheimer	Outperform → Perform
Jun-22-22	Initiated	H.C. Wainwright	Buy
Apr-06-22	Downgrade	Truist	Buy → Hold
Jan-28-22	Initiated	Oppenheimer	Outperform
Nov-24-21	Initiated	Morgan Stanley	Equal-Weight

View All

Celularity Inc Stock (CELU) Latest News

Jul 01, 2026

Celularity Inc. Warrant 2021-16.07.26 on Celularity -A- Financial Disclosures & SEC Filings - TradingView

Jul 01, 2026

Jun 30, 2026

Celularity Inc. Announces Resignation of Vincent LeVien as Director, Effective June 26, 2026 - marketscreener.com

Jun 30, 2026

Celularity Inc. Enters into a Loan Agreement with the Philip & Daniele Barach Family Trust - marketscreener.com

Jun 30, 2026

Celularity Inc. Secures $1 Million Loan from Philip & Daniele Barach Family Trust – Form 8-K Filing Details and Key Agreement Terms 141519 - Minichart

Jun 30, 2026

Celularity Secures $1 Million Bridge Loan From Barach Family Trust, Due in 30 Days or Financing - TradingView

Jun 30, 2026

Insider trust lends $1M to Celularity (NASDAQ: CELU) on short term - Stock Titan

Jun 30, 2026

Jun 28, 2026

Enterprise value to EBIT forward of Celularity Inc. – NASDAQ:CELU - TradingView

Jun 28, 2026

Enterprise value to EBITDA forward of Celularity Inc. – NASDAQ:CELU - TradingView

Jun 28, 2026

Price to sales forward of Celularity Inc. – NASDAQ:CELU - TradingView

Jun 28, 2026

Jun 26, 2026

Celularity Inc (NASDAQ: CELU) Share Price, CELU Stock News, CELU Share Price & Updates - Kalkine

Jun 26, 2026